Archive · 21 Jul 2026
Testosterone Therapy Safe for Low-Risk Prostate Cancer
For a long time, doctors thought testosterone could make prostate cancer worse, so they didn't recommend testosterone replacement therapy (TRT) for men with prostate cancer.
But new research shows that for men with low-risk prostate cancer and low testosterone, TRT might be safe when carefully monitored.
Studies found that TRT didn't increase cancer progression or the need for treatments like surgery or radiation.
However, experts say it's important to keep checking PSA levels, do regular biopsies, and see doctors often.
This way, TRT can help improve quality of life without big risks.
But it's only for certain men, and more research is needed to be sure.
Testosterone replacement therapy (TRT) is now considered safe for men with low-risk, localized prostate cancer and hypogonadism under close medical supervision.
Historically, TRT was avoided due to concerns it could fuel prostate cancer growth, but new research challenges this belief.
The androgen saturation model suggests prostate cells become saturated with testosterone at low levels, limiting additional tumor growth.
Studies found no significant increase in cancer progression or need for treatments like surgery or radiation in men receiving TRT.
Regular PSA testing, biopsies, and imaging are essential for monitoring patients on TRT.
- Who
- Men with low-risk, localized prostate cancer and hypogonadism.
- What
- Testosterone replacement therapy (TRT) and its safety in prostate cancer patients.
- When
- Current research and historical context of TRT use in prostate cancer.
- Where
- Global medical research and clinical practice.
- Why
- To improve quality of life for men with low testosterone and prostate cancer without increasing cancer risk.
Proponents of Testosterone Therapy
Skeptics of Testosterone Therapy
Safety in Low-Risk Cases
Proponents of Testosterone Therapy
Testosterone replacement therapy (TRT) is safe for men with low-risk, localized prostate cancer and hypogonadism when closely monitored.
Skeptics of Testosterone Therapy
TRT could potentially fuel prostate cancer growth, even in low-risk cases, and more research is needed.
Impact on Cancer Progression
Proponents of Testosterone Therapy
TRT does not significantly increase the risk of cancer progression in carefully selected patients.
Skeptics of Testosterone Therapy
The long-term effects of TRT on cancer progression are still uncertain and require further study.
Need for Comprehensive Monitoring
Proponents of Testosterone Therapy
Regular PSA testing, biopsies, and imaging are sufficient to monitor patients on TRT.
Skeptics of Testosterone Therapy
Comprehensive monitoring may not be enough to detect all potential risks associated with TRT.
- Hypogonadism
- A condition where the body produces insufficient testosterone.
- Testosterone Replacement Therapy (TRT)
- Therapy to increase testosterone levels in individuals with hypogonadism.
- Prostate-Specific Antigen (PSA)
- A marker used to monitor prostate health and cancer progression.
- Androgen Saturation Model
- Theory suggesting prostate cells become saturated with testosterone at low levels, limiting additional tumor growth.
- Active Surveillance
- Monitoring prostate cancer without immediate treatment, suitable for low-risk cases.